Dermatology
News
FDA is investigating Zecuity sumatriptan patch for reports of serious burns
News
Anxiety before Mohs surgery can be easily managed
News
Stevens-Johnson syndrome, TEN not as rare as thought
Stevens-Johnson syndrome and toxic epidermal necrolysis are not quite as rare as previously thought.
Conference Coverage
For preventing AKs, 5-FU beats placebo for up to 3 years
Key clinical point: One course of topical 5-fluorouracil was effective and durable in preventing new actinic keratoses in high-risk patients....
News
FDA: No oral ketoconazole for skin, nail fungus
News
Diabetic foot ulcers linked to cognitive decline
Key clinical point: Among patients with type 2 diabetes, those with foot ulcers show cognitive impairment, compared with those who don’t have foot...
Conference Coverage
Serious infections are increasing among psoriasis inpatients
Key clinical point: Psoriasis is an independent risk factor for serious infections, and serious infections are increasing among inpatients with...
Conference Coverage
Crisaborole’s safety holds up in long-term atopic dermatitis trial
Key clinical point: The topical phosphodiesterase-4 inhibitor crisaborole was safe and well tolerated for up to 48 weeks in patients with mild-to-...
News
Atopic dermatitis increases risk of ADHD, comorbidities add to it
Atopic dermatitis (AD) is associated with an increased risk for attention-deficit/hyperactivity disorder (ADHD) in children and adults, and a...
Conference Coverage
Study lays groundwork for refractory cutaneous lupus treatment algorithms
Key clinical point: Thalidomide, methotrexate, dapsone, and belimumab may be the best alternatives for patients whose cutaneous lupus...